搜尋結果
JPMorgan says there's a new GLP-1 drug player and its shares can rally 80%
CNBC· 3 日前Structure Therapeutics is an overlooked player in the GLP-1 market, and could one ...
US FDA staff says Guardant's test may fail to detect some pre-cancerous tumors
Reuters· 3 日前, opens new tab experimental blood test for a cancer of colon or rectum may fail to detect some ...
Nestle set to sell $5 pizza, sandwiches for Wegovy, Ozempic users
Reuters· 3 日前, opens new tab will market a new, $5 line of frozen pizzas and protein-enriched pastas ... ...
Nestle to launch Vital Pursuit frozen-food brand targeting GLP-1 users
CNBC· 3 日前Nestle is launching a new frozen-food brand, Vital Pursuit, aimed at the growing & ...
China Clears Eli Lilly’s Weight-Loss Drug, Only for Diabetes Now
Bloomberg· 3 日前Have a confidential tip for our reporters? China gave the greenlight to Eli Lilly ...
AstraZeneca targets $80 billion in total revenue by 2030 in 'post-Covid era'
CNBC· 3 日前LONDON — Pharmaceutical company AstraZeneca on Tuesday said it planned to increase its total ...
London stocks fall as Fed's cautious stance weighs on sentiment
Reuters· 3 日前London stocks slipped on Tuesday, tracking weakness in Asian markets as U.S. Federal ... ...
Eli Lilly's diabetes drug tirzepatide gets approval in China
Reuters· 3 日前Novo Nordisk's popular diabetes drug Ozempic won approval from China in 2021 and the ...
GSK’s Potential Blockbuster Asthma Drug Shows Promise in Latest Trial
The Wall Street Journal· 3 日前GSK said two late-stage trials of an asthma drug that could have peak sales of almost $4 ...
Nestlé Launching Frozen Food Brand For Ozempic Users
Forbes· 3 日前Vital Pursuit will be packed with a variety of nutrients, such as protein, vitamin A